摘要
目的分析儿童静脉畸形予以介入治疗的临床疗效与可行性。方法整群选取2013年6月—2015年5月该院收治的58例儿童静脉畸形患儿,随机分为观察组(以聚桂醇为硬化剂)与对照组(以平阳霉素为硬化剂)各29例,对比两组患者的介入治疗效果。结果观察组的总有效率与对照组比较差异无统计学意义(χ2=2.58;P<0.05);且观察组患儿的平均介入治疗次数与不良反应率分别为(1.07±0.64)次/例、10.35%,均明显低于对照组,差异有统计学意义(t=12.19,χ2=5.29;P<0.05)。结论相较于平阳霉素,聚桂醇作为硬化剂进行介入硬化治疗的效果更为明显,利于病情康复,安全可靠。
Objective To analyze the venous malformation children to be involved in the clinical efficacy and feasibility of therapy. Methods Group selection June 2013 - May 2015 were treated 58 cases of venous malformation children were ran-domly divided into two groups （with ethanol as a hardener） and control group （in Pingyangmycin hardener） each 29 cases, compared to the two groups were involved in the therapeutic effect. Results The total effective rate of observation group 86.21%, higher than the control （χ^2= 6.58; P﹤0.05）; and observation of children involved in the group Average number of treatment and adverse reaction rates were to （1.07 ± 0.64） times /Cases , 10.35%, significantly lower than the control group, the difference was significant （t = 12.19, χ^2= 5.29; P﹤0.05）. Conclusion Compared to PYM, ethanol as a hardener hard-ening interventional therapy effect is more obvious, conducive to disease rehabilitation, safe and reliable.
出处
《中外医疗》
2016年第18期59-60,共2页
China & Foreign Medical Treatment
关键词
儿童静脉畸形
介入治疗
硬化剂
临床效果
Children arteriovenous malformation
Interventional therapy
Hardener
Clinical effect
